Eastover Investment Advisors LLC Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Eastover Investment Advisors LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.1% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 4,319 shares of the medical equipment provider’s stock after acquiring an additional 46 shares during the quarter. Intuitive Surgical accounts for 1.0% of Eastover Investment Advisors LLC’s portfolio, making the stock its 27th largest position. Eastover Investment Advisors LLC’s holdings in Intuitive Surgical were worth $2,139,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $25,000. Parvin Asset Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $28,000. Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $28,000. Finally, Summit Securities Group LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. Erste Group Bank downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the company a “buy” rating in a research report on Monday, April 14th. Citigroup reiterated a “buy” rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Truist Financial reduced their target price on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a report on Wednesday, April 23rd. Finally, Barclays reduced their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $596.05.

Insiders Place Their Bets

In other news, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now directly owns 6,371 shares of the company’s stock, valued at approximately $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,695,113.84. The trade was a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 30,111 shares of company stock worth $15,364,055 over the last quarter. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of ISRG opened at $555.75 on Friday. The stock’s 50-day moving average is $515.81 and its two-hundred day moving average is $538.43. The stock has a market cap of $199.19 billion, a PE ratio of 86.70, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12 month low of $396.48 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the previous year, the firm posted $1.50 earnings per share. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.